Julissa Vianna
Vice President of Corporate Communications, Investor Relations, and Patient Advocacy
Replay available
Verastem, Inc. (NASDAQ: VSTM) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Vice President of Corporate Communications, Investor Relations, and Patient Advocacy
President and Chief Executive Officer
President of Development
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Verastem, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.456 Good afternoon and welcome to VeriSTEM 00:00:04.456 -- 00:00:09.882 Oncology's first quarter 2026 earnings conference call. 00:00:09.882 -- 00:00:13.646 My name is Daniel and I will be your call operator today. 00:00:13.646 -- 00:00:16.869 Please note this event is being recorded. 00:00:16.869 -- 00:00:20.273 All participants will be in a listen-only mode. 00:00:20.273 -- 00:00:26.119 After today's presentation, there will be an opportunity to ask questions. 00:00:26.119 -- 00:00:30.693 I will now turn the call over to Julissa Vianna 00:00:30.693 -- 00:00:35.298 Vice President of Corporate Communications, Investor Relations, 00:00:35.298 -- 00:00:39.642 and Patient Advocacy for Verisim Oncology. 00:00:39.642 -- 00:00:42.183 Please go ahead. 00:00:51.815 -- 00:00:53.497 Thank you, operator. 00:00:53.497 -- 00:00:57.461 Welcome, everyone, and thank you for joining us today to discuss Verisim's first quarter 00:00:57.461 -- 00:01:01.975 2026 financial results. and recent business updates. 00:01:01.975 -- 00:01:05.759 This afternoon, we issued a press release detailing these results, along with the slide 00:01:05.759 -- 00:01:09.123 presentations that will be referenced during our call today. 00:01:09.123 -- 00:01:13.407 Both are available on the investor relations section of our website. 00:01:13.407 -- 00:01:17.692 Before we begin, let me point out that we'll be making forward-looking statements that 00:01:17.692 -- 00:01:20.755 are based on our current expectations and beliefs. 00:01:20.755 -- 00:01:24.639 These statements are subject to certain risks and uncertainties, and actual results may 00:01:24.639 -- 00:01:29.136 differ materially. we encourage you to consult the risk factors discussed in our SEC 00:01:29.136 -- 00:01:31.778...